Carbon dioxide vs air insufflation for elective colonoscopy: a meta-analysis and systematic review of randomized controlled trials by Memon, Muhammed A. et al.
1 
 
TITLE 
Carbon dioxide vs air insufflation for elective colonoscopy: A meta-analysis and systematic review of 
randomized controlled trials 
 
AUTHORS (EMAILS) 
Muhammed Ashraf Memon, MBBS, MA Clin Ed, DCH, FRACS, FRCSI, FRCSEd, FRCSEng, 
FACS1,2,3,4,5 (mmemon@yahoo.com) 
Breda Memon, RGN, LLB, PGCEd1 (bmemon@yahoo.com) 
Rossita Mohamad Yunus, PhD6 (rossita@um.edu.my) 
Shahjahan Khan, PhD5 (Shahjahan.khan@usq.edu.au) 
 
DEPARTMENTS AND INSTITUTIONS 
1South East Queensland Surgery (SEQS) and Sunnybank Obesity Centre, Suite 9, McCullough 
Centre, 259 McCullough Street, Sunnybank, Queensland, Australia 
2Mayne Medical School, School of Medicine, University of Queensland, Brisbane, Queensland, 
Australia 
3Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia 
4Faculty of Health and Social Science, Bolton University, Bolton, Lancashire, UK 
5School of Agricultural, Computing and Environmental Sciences, International Centre for Applied 
Climate Sciences and Centre for Health Sciences Research, University of Southern Queensland, 
Toowoomba, Queensland, Australia 
6Institute of Mathematical Sciences, University of Malaya, Kuala Lumpur, Malaysia 
 
REPRINTS/CORRESPONDENCE 
Professor M. A. Memon, FRCS, FRACS, AFACS Sunnybank Obesity Centre, Suite 9, McCullough 
Centre, 259 McCullough Street, Sunnybank, QLD 4109, Australia 
Tel: +61 7 3345 6667  Fax: +61 7 3344 1752  Mobile: +61 448614170 
Email: mmemon@yahoo.com 
2 
 
 
SECTION OF THE JOURNAL 
Meta-analysis/Systematic Reviews 
 
KEY WORDS 
Colonoscopy; Carbon dioxide; Air; Randomized controlled trials; Human 
 
Accepted for Oral Presentation at the American College of Surgeon’s Clinical Congress 2015; 
McCormick Place, Chicago Illinois; Forum Colon and Rectal Surgery V; 8th October, 2015 
3 
 
STRUCTURED ABSTRACT: 
 
Aims and objective: The aim was to conduct a meta-analysis and systematic review of RCTs 
comparing two methods of colonic insufflation for elective colonoscopy i.e. carbon dioxide or air and 
to evaluate their efficiency, safety and side effects. 
 
Material and Methods: Prospective RCTs comparing carbon dioxide versus air insufflation for 
colonic distension during colonoscopy were selected by searching PubMed, Medline, Embase, 
Science Citation Index, Current Contents, and the Cochrane Central Register of Controlled Trials 
published between January 1980 and October 2014.The outcome variables analyzed included 
procedural and immediate post-procedural pain (during, end or within 15 min after procedure), early 
post-procedural pain (between 30-120 min), intermediate post-procedural pain (360 min) and late 
post-procedural pain (720-1140 min), cecal/ileal intubation rate, cecal/ileal intubation time, and total 
colonoscopy examination time. These outcomes were unanimously decided to be important since they 
influence the practical approach towards patient management within and outside of hospital. Random 
effects model was used to calculate the effect size of both binary and continuous data. Heterogeneity 
amongst the outcome variables of these trials was determined by the Cochran Q statistic and I2 index. 
The meta-analysis was prepared in accordance with PRISMA guidelines.  
 
Results: Twenty four RCTs totaling 3996 patients (CO2=2017, Air=1979) were analyzed. Statistical 
significant differences for the pooled effect size were observed for procedural and immediate post-
procedural pain (WMD 0.49, 95% CI 0.32, 0.73, p= 0.0005), early post-procedural pain between 30 
and 120 minutes (WMD 0.25, 95% CI 0.12, 0.49, p=<0.0001), intermediate post-procedural pain i.e. 
360 minutes post completion (WMD 0.35, 95% CI 0.23, 0.52, p=<0.0001) and late post-procedural 
pain, between 720 and 1440 minutes (WMD 0.53, 95% CI 0.34, 0.84, p=0.0061). Comparable effects 
were noted for cecal/ileal intubation rate (WMD 0.86, 95% CI 0.61, 1.22, p=0.3975), cecal/ileal 
intubation time (WMD -0.64, 95% CI -1.38, 0.09, p=0.0860) and total examination time (WMD -
0.20, 95% CI -0.96, 0.57, p=0.6133).  
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Conclusions: On the basis of our meta-analysis and systematic review, we conclude that carbon 
dioxide insufflation significantly reduces abdominal pain during and following the procedure lasting 
up to 24 hours. There is no difference in the cecal/ileal intubation rate and time and total examination 
time between the two methods. Carbon dioxide retention with CO2 insufflation during and after the 
colonoscopy shows inconsequential variation compared to air insufflation and has no adverse effect 
on patients. Carbon dioxide instead of air should be routinely utilized for colonoscopy.  
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INTRODUCTION: 
Air insufflation is essential to distend the colonic lumen to obtain optimum visualization during 
colonoscopy. However this may result in the patient suffering from pain and nausea, both during and 
in the recovery phase following completion of the procedure. This is because trapped unabsorbed air 
can remain in the colon for prolonged period of time resulting in protracted bowel distension, which 
can lengthen the patient discomfort in the post-procedural period due to (a) of risk of bowel ischemia 
and (b) increased spasm. Some patients can experience substantial abdominal pain which can be 
confused with colonic perforation requiring unnecessary hospitalization and radiological 
investigations to rule out this complication. In 1953, Becker1 recommended the use of carbon dioxide 
(CO2) insufflation to eliminate the risk of electrocoagulation colonic gas explosion. In 1985, Coblentz 
et al2 first described the beneficial effects of CO2 instead of air during double contrast barium enema 
study. The authors found a significant reduction in the post procedural incidence of moderate to 
severe pain from 30% to 11% by the use of CO2. They also demonstrated the rapid absorption of CO2 
from the gut, as evident from the abdominal radiographs at 1 hour. A similar study by Williams3 in 
1986 confirmed the superiority of CO2 for double contrast barium enema. Roger4 was the first to 
evaluate the feasibility of CO2 insufflation during colonoscopy. Since then a number of studies5,6 have 
shown the beneficial effect of CO2 insufflation as fewer patients complained of abdominal pain during 
the procedure if they are not sedated, and following the completion of colonoscopy. This may be 
because of faster CO2 absorption by the intestinal mucosa, up to 150 times faster than air3. However 
there remains the concern regarding temporary increase in CO2 concentration in the blood with 
adverse respiratory consequences either during or after completion of colonoscopy. 
 
Air insufflation still remains the standard method of colonic insufflation for colonoscopy in the vast 
majority of centers around the world. Until recently this was partly because of a lack of dedicated CO2 
insufflators adequately tailored for colonoscopy, cost issue and fear of respiratory complications 
especially in elderly patients. Nevertheless in the last 32 years a number of randomized controlled 
trials (RCTs) comparing air and CO2 insufflation have been published analyzing various aspects of 
these two approaches. The objective of this meta-analysis and systematic review was to determine the 
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clinical outcomes, safety, effectiveness and side effects of these two methods of insufflation for 
colonoscopy. 
 
MATERIALS AND METHODS: 
Literature Search Strategy, Study Selection and Data Collection 
Electronic databases (PubMed, Medline, Embase, Science Citation Index, Current Contents and the 
Cochrane Central Register of Controlled Trials) were search for RCTs published between January 
1980 and October 2014 using medical subject headings (MeSH); “colonoscopy,” “insufflation,” “air,” 
“carbon dioxide/CO2,” “abdominal pain,” “comparative study,” “prospective studies,” 
“randomized/randomised controlled trial,” “random allocation,” ‘clinical trial,” “complications,” and 
“human”. A further search was undertaken of the bibliographies of all included primary studies and 
existing reviews and meta-analyses for additional citations. Data extraction, critical appraisal and 
quality assessment of the identified studies were carried out by two authors (BM, MAM). The authors 
were not blinded to the source of the document or authorship for the purpose of data extraction. 
Standardized data extraction form7 was used by authors to independently and blindly summarize all 
the data available in the RCTs which was then entered directly into MS Word tables. Double data 
entry method was used in order to avoid errors in data extraction. The data were compared and 
discrepancies were addressed with discussion until consensus was achieved. The analysis was 
prepared in accordance with the Preferred Reporting of Systematic Reviews and Meta-Analyses 
(PRISMA) statement8. Random effects model was used for analysis of all the outcome variables.  
 
Eligibility Criteria 
Two reviewers (BM and MAM) individually considered the abstracts of the identified articles for 
potential eligibility. All the eligible full text articles were reviewed in detail and checked against our 
inclusion and exclusion criteria. Appropriateness was determined by these independent reviewers and 
by discussion in case of inconsistency. The RCTs must have reported on at least one clinically 
relevant outcome pertaining to the procedural and post-procedural period. Outcomes assessed were 
those considered to exert influence over practical aspects of medical/surgical practice and patient 
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management. All studies reporting on outcomes of this nature were considered and final analyses 
were run on outcome variables where numbers were sufficient to allow statistical analysis.  
 
Inclusion Criteria 
1. Type of Study: Only randomized controlled trials published in full in peer-reviewed journals 
between January 1980 and October 2014 were included for analysis.  
2. Language: No language restriction was applied 
3. Types of Intervention: Two different methods of colonic insufflation for elective full 
colonoscopy (i.e. from anus to caecum/terminal ileum), namely CO2 versus air for the entire 
procedure were being assessed.  
4. Indications: No restrictions on indications for colonoscopy were applied. 
5. Type of participants: Only adult (>16 years) patients were the target population for this 
meta-analysis. 
 
Exclusion Criteria 
1. Prospective non-randomized controlled trials, retrospective and case controlled studies.  
2. Ongoing unpublished RCTs and their abstracts 
3. Duplicate publications 
4. RCTs of CO2 vs air insufflation for flexible sigmoidoscopy (and not full colonoscopy)6  
5. RCTs comparing water immersion versus CO2 insufflation 
6. RCTs comparing CO2 vs air insufflation where CO2 was only used during withdrawal and not 
for the entire procedure9 
  
Types of Outcome Measures Analyzed 
1. Procedural and immediate post-procedural pain (during, end of procedure or within 15 min 
after completion) 
2. Early post-procedural pain (between 30-120 min after completion)  
3. Intermediate post-procedural pain (360 min after completion)  
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4. Late post-procedural pain (720-1140 min after completion)  
5. Cecal/ileal intubation rate  
6. Cecal/ileal intubation time  
7. Total colonoscopy examination time  
There were three other outcome variables, which although could not be quantitatively analyzed, were 
qualitatively analyzed and include: 
8. CO2 measurement during colonoscopy  
9. CO2 measurement post-procedural 
10. CO2 utilization during colonoscopy 
 
Methodological Quality 
The methodological quality of the identified RCTs was assessed using Jadad Scoring system10. Each 
study was allocated a score from zero to five, zero being the lowest quality and five being the highest 
quality based on reporting of randomization, blinding, and withdrawals reported during the study 
period.  
 
Statistical Analysis and Risk of bias across Studies 
Meta-analysis were performed using odds ratios (ORs) for binary outcome and weighted mean 
differences (WMDs) for continuous outcome measures. Data was pooled using the Mantel-Haenszel 
and the inverse variance method for binary and continuous outcomes respectively. The slightly 
amended estimator of OR was used to avoid the computation of reciprocal of zeros among observed 
counts in the calculation of the original OR11. DerSimonian and Laird random effects model was used 
to combine the data12. This is because in clinical practice, differences in patient demographics, health 
care practitioner skills etc. render the assumptions of the fixed effects model void when evaluating 
therapeutic or clinical interventions. Heterogeneity among studies was calculated using the Q statistic 
proposed by Cochran and I2 index introduced by Higgins and Thompson12-16. If the observed value of 
Q was greater than the associated x2 critical value at a given significant level, in this case 0.05, we 
conclude the presence of statistically significance between-studies variation. In order to pool 
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continuous data, mean and standard deviation of each study is required. However, some of the 
published clinical trials did not report the mean and standard deviation, but rather reported the size of 
the trial, the median and interquartile range. Using these available statistics, estimates of the mean and 
standard deviation were obtained using formulas proposed by Hozo et al17. Funnel plots were 
produced in order to determine the presence of publication bias in the present meta-analysis. Both 
total sample size and precision (reciprocal of standard error) were plotted against the treatment effects 
(OR for binary variables and WMD for continuous variables)12,18-20. All estimates were obtained using 
a computer program written in R21. All plots were obtained using the metafor-package22. In the case of 
tests of hypotheses, the paper reports p-values for different statistical tests on the study variables. In 
general, the effect is considered to be statistically significant if the p-value is small. If one uses a 5% 
significance level then the effect is significant only if the associated p-value is ≤5%. 
 
RESULTS: 
Included Studies 
Cross searching of electronic databases yielded a total of 65 abstracts and hand searches of reference 
lists provided a further 7 citations. After exclusion of non-relevant citations, 32 unique citations of 
potential relevance were retrieved for review. The process by which these citations were excluded is 
described in Figure 1. There was almost perfect agreement (κ=0.99) between two authors (BM and 
MAM) regarding inclusion of these RCTs. No further potentially relevant unpublished studies were 
identified through a citation search of previous published reviews and meta-analyses on this subject. 
Twenty four randomized controlled trials met the inclusion criteria23-46. None of the RCTs were 
involved in the presentation of data beyond 24 hour follow-up and therefore duplication of data was 
not an issue (Fig 1). As no language restriction was applied, RCTs published on this subject in any 
language were included in our meta-analysis. 
 
Methodological Quality 
In general, the quality of RCTs demonstrated very good methodological quality based on Jadad 
scoring criteria with an average score of 4 (out of five), with a range of 1 to 5 (Table 1).  
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Heterogeneity 
The Q test and I2 Index are commonly used methods in meta-analysis for detecting heterogeneity. 
Significant heterogeneity i.e. I2 index of 50% or more16 was observed for a number of outcome 
variables (Table 2). This reflects differences in patient population, outcome measure, definition of 
variables, and follow-up of the individual RCTs included in this meta-analysis.  
 
Publication Bias 
A number of the funnel plots demonstrate asymmetry (dots outside the triangle) suggesting the 
presence of publication bias based on a large number of studies included in this meta-analysis (Fig 2). 
 
Clinical Outcomes  
Twenty four RCTs totaling 3996 patients (CO2=2017, Air=1979) were analyzed23-46. For four out of 
the seven analyzable outcomes, the pooled effect size favored CO2 insufflation over air with 
statistically significant reduction for procedural and immediate post-procedural pain (WMD 0.49, 
95% CI 0.32, 0.73, p= 0.0005) (Fig 3, Table 2), early post-procedural pain between 30 and 120 
minutes (WMD 0.25, 95% CI 0.12, 0.49, p=<0.0001) (Fig 4, Table 2), intermediate post-procedural 
pain i.e. 360 minutes post completion (WMD 0.35, 95% CI 0.23, 0.52, p=<0.0001) (Fig 5, Table 2) 
and late post-procedural pain, between 720 and 1440 minutes (WMD 0.53, 95% CI 0.34, 0.84, 
p=0.0061) (Fig 6, Table 2). Comparable effects were noted for cecal/ileal intubation rate (WMD 0.86, 
95% CI 0.61, 1.22, p=0.3975) (Fig 7, Table 2), cecal/ileal intubation time (WMD -0.64, 95% CI -
1.38, 0.09, p=0.0860) (Fig 8 Table 2) and total examination time (WD -0.20, 95% CI -0.96, 0.57, 
p=0.6133) (Fig 9, Table 2).  
 
Brief description of various RCTs 
Salient features of various RCTs comparing CO2 vs air insufflation are detailed in Table 3. Ten 
RCTs24,26,27,30,31,34,25,36,42,44 had more than 100 patients in both arms. Appraisal of post-procedural pain 
was undertaken subjectively at various time points depending on the study protocol. The vast majority 
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of studies used visual analogue scale (VAS) for this purpose. To appraise patients’ pain experience, 
either telephone survey was carried out or patients were provided the questionnaire prior to their 
discharge and were requested to fill them up promptly the next day and mailed them back to their 
respective centers in a prepaid envelope.  Routine sedation was not used in 9 RCTs24,26,30,32,33,38,39,44,45. 
Only three trials were multicenter28,41,45 whereas the majority of them originated from a single center. 
Indications for colonoscopy varied i.e. diagnostic ± screening ± surveillance. Most of the 
colonoscopists participating in these RCTs seem to be quite experienced although the exact details are 
lacking. The shortest post-procedural follow-up was 10 minutes and longest being 1440 minutes. 
Complications were extremely rare (Table 4). Two RCTs26,33 were designed to measure gas volumes 
between the groups. Two RCTs performed plain abdominal radiology to evaluate retention of bowel 
gas23,25. One RCT46 specifically compared the toilet usage following colonoscopy between the two 
groups. Ten24,28,30,32-35,39,41,43 and nine24,28,30,32-34,39,41,43  RCTs respectively provided gas measurement 
during and after colonoscopy using various methodologies (Table 5). 
 
DISCUSSION: 
Effect of CO2 vs air insufflation on abdominal pain 
With a total of 3996 patients (CO2=2017, Air=1979), this is the largest body of comparative clinical 
data evaluated to date for CO2 vs air insufflation for elective colonoscopy in adult patients. Based on 
the pooled effect size for various time points in relation to pain, CO2 seems to have superiority over 
air. Sixteen RCTs23-25,27-31,33-36,40,42,44,46 have reported on procedural and immediate post-procedural 
pain i.e. during, end or within 15 minutes following procedure. The pooled effect size showed a 
statistically significant larger number of patients, who were pain free following CO2 insufflation 
versus air (947/1484 vs 700/1470, p=0.0005) (Fig 3). This trend continued to be observed (a) in the 
early post-procedural period i.e. between 30 minutes to 120 minutes reported by 13 studies consisting 
of 2196 patients24,25,28-31,33,34,36,40,42,43,46 (Fig 4); (b) in the immediate post-procedural period i.e. 360 
minutes reported by 11 studies consisting of 1666 patients23-25,28,30,31,33,34,39,40,43 (Fig 5); and in the late 
post-procedural period i.e. between 720 to 1440 minutes reported by 12 studies consisting of 1909 
patients23-25,28,30,31,33,34,36,39,43,44 (Fig 6). Therefore it is evident that trapped unabsorbed colonic air 
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compared to CO2 is the cause of the patient’s abdominal discomfort due to prolonged bowel 
distension and accompanying rise in intraluminal pressure during and in the post-procedural period 
with consequent increase in the severity and extent of interference with colonic mucosal blood 
flow47,48. On the other hand rapid absorption of CO2 via the intestinal mucosa into the blood and then 
being eliminated via respiration leads to significantly less bowel distension, abdominal pain and 
interference with colonic mucosal blood flow leading to quicker patient recovery. If one looks at the 
utility and effectiveness of treatment, when CO2 is used instead of air for colonoscopy, the 
effectiveness is no different (see technical data below), the abdominal pain is significantly less, and 
the economic gain to patients and the employer if they return to work quicker favors the use of CO2 
although no such data is available in any of the RCTs. Newcomer et al49 revealed post-colonoscopic 
pain results in missed work days in 4% of patients which has important financial implications both for 
the patients and the employers. As the prospect of widespread colonoscopic screening for colorectal 
cancer in the asymptomatic aging populations in the first world countries is gaining momentum and 
the demand for colonoscopy is becoming very high50,51, it should therefore be a clinical priority to 
perform this procedure with least discomfort which leads to better acceptance and higher compliance 
by the population assuring the success of a mass colonoscopic screening program which will 
ultimately save lives.  
 
Colonoscopy technical data 
We further compared the technical data for colonoscopy performed using air and CO2. Cecal/ileal 
intubation rates were reported by 13 (n=2281) RCTs24,26,27,29-31,33,34,36,41,43-45 (Fig 7, Table 1). The 
pooled data showed comparable outcomes for CO2 and air (p=0.3975). The cecal/ileal intubation time, 
reported by 16 RCTs24,26,27,29,31-36,38,39,41,43,44,46, however the analyzable data was available for 14 RCTs 
(n=2331) and total examination time i.e. from the time of insertion of the scope until its withdrawal, 
was reported by 19 RCTs25-27,30-36,38-46, however analyzable data was available for 17 RCTs (n=2905). 
Both of these variables showed no difference between the two groups (p=0.0860 and p=0.6133 
respectively) (Fig 8 and 9, Table 2). Procedure related adverse effects or complications were reported 
by 11 RCTs24,29,31-33,37,39,40,43,44,46. They were extremely rare and no differences were noted between the 
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two groups (Table 4). It is entirely possible that the lack of any difference in technical data between 
the two groups may be related to experienced colonoscopists performing colonoscopy, however the 
exact description of “experience colonoscopists” is not provided by all of these trials and in others, the 
experience of colonoscopist was stated in years (e.g. 10 years) or number of scopes (e.g. 3000) 
performed by the them.  
 
Safety and Effectiveness of CO2 vs Air 
Carbon dioxide is an end product of cellular respiration in organisms that obtain energy by breaking 
down sugars, fats and amino acids with oxygen as part of their metabolism. In humans, this CO2 is 
carried through the venous system and is breathed out through the lungs. Therefore, the CO2 content 
in the body is high in the venous system, and decreases in the respiratory system, resulting in lower 
concentrations along any arterial system. In concentrations up to 1% (10,000 ppm), it will make some 
people feel drowsy. Concentrations of 7% to 10% may cause suffocation, even in the presence of 
sufficient oxygen, manifesting as dizziness, headache, visual and hearing dysfunction, and 
unconsciousness within a few minutes to an hour. The physiological effects of acute CO2 exposure are 
grouped together under the term hypercapnia, a subset of asphyxiation. Hypercapnia is generally 
caused by hypoventilation, lung disease (COPD), or diminished consciousness (sedated patients). It 
may also be caused by exposure to environments containing abnormally high concentrations of CO2 
or by rebreathing exhaled CO2. Hypercapnia is generally defined as a blood gas CO2 level over 45 
mmHg. Since CO2 is in equilibrium with carbonic acid in the blood, hypercapnia can drive serum pH 
down, resulting in a respiratory acidosis. The question whether exposure to CO2 during colonoscopy 
produces undesirable effects such as high concentration of CO2 in deeply sedated patients and 
especially in a group of patients suffering from pulmonary diseases? A number of previous studies 
have convincingly shown this not to be the case24,28,52. The end tidal CO2 (ETCO2) in unsedated 
patients will diminish because of hyperventilation24, whereas in sedated or anaesthetized patients the 
ETCO2 will increase slightly28,52. All these changes are transient and physiological and do not lead to 
any clinical consequences. We qualitatively analyzed the data from 10 RCTs (n=1471)24,28,30,32-35,39,41,43 
to see if the patients who were receiving CO2 compared to air had higher CO2 concentration measured 
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by various means (End tidal CO2, processed transcutaneous CO2, transcutaneous pCO2 or using 
capnography) during and at the end of the procedure. Five RCTs28,34,35,41,43 routinely sedated their 
patients. Even then, no significant rise in CO2 was noted for the group insufflated with CO2. The 
measured values for CO2 for most patients remained within normal limits both during and at the end 
of colonoscopy (Table 5). Bretthauer et al28 showed that in sedated patients in both the CO2 and air 
groups, there was a slight increase in ETCO2 values. The authors felt that it was sedation causing 
hypoventilation, which was the primary cause of CO2 retention, rather than CO2 insufflation. Other 
authors33 feel that besides reduced rate of respiration during sedation, the positioning of the patients 
during colonoscopy i.e. left lateral position effects the movement of diaphragm, ribs and intercostal 
muscles, may lead to CO2 retention even if air is insufflated for colonoscopy. Geyer et al34 further 
showed that in sedated patients even who have pulmonary disorders including COPD, CO2 
insufflation did not produce any detrimental effects and they felt that “this makes it possible to 
transfer their data to a screening population without any restrictions”.  Similarly Singh et al41 came to 
the same conclusion in their RCT as COPD patients were not excluded from their study and none of 
their patients suffered respiratory adverse effects even after receiving CO2 for colonoscopy. They felt 
that the major limitation of their study was measurement of CO2 via capnography which may not be 
very accurate. Our analysis therefore confirms the findings of previous RCTs that CO2 does not 
produce detrimental side effects even in sedated patients during colonoscopy even when CO2 is 
continuously pumped to inflate the colon (Table 5, Fig 10 & 11). However one can argue that CO2 
concentration measurement will be dependent on the volume insufflated during colonoscopy. Only 
two RCTs26,33 have provided data on the volume of CO2 used during the procedure. Bretthauer et al26 
measured the gas volumes in 218 out of 249 patients. The authors found comparable volumes of CO2 
and air were insufflated per minutes. However statistically significant differences in the volume of gas 
insufflation were noticed amongst some of the less experienced endoscopists, who utilized far more 
CO2 during colonoscopy. However they did not correlate the volume findings with CO2 concentration. 
Yamano et al33 on the other hand analyzed their 120 patients and compared their finding to Bretthauer 
et al’s study26. They observed that the mean gas volume and gas flow rate and the maximum gas 
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volume used in CO2 cohort was much higher compared to Bretthauer et al’s study26. However this did 
not lead to any abnormal increase in pCO2 suggesting the safety of CO2.  
 
As far as the effectiveness of CO2 insufflation is compared with air insufflation, cecal/ileal intubation 
rates, cecal/ileal intubation time, and total examination time i.e. from the time of insertion of the 
scope until its withdrawal were comparable with no differences in adverse effects. We further 
investigated the role of polyp/adenoma detection rates between the two insufflation types but there 
was insufficient data to comment on this issue. There are only three RCTs27,31,36 which have provided 
us some details regarding polyps/adenoma detection rates which seems to be similar between the two 
insufflation methods although the details are lacking. We therefore strongly feel that as all the other 
colonoscopy quality indicators for both insufflation processes were similar, the issue of 
polyps/adenoma detection rate should remain similar for CO2 and air insufflation. The polyp/adenoma 
detection rate depends on other factors such as operator experience, quality of bowel preparation, type 
of colonoscope, withdrawal time and previous history of colorectal polyps/cancer to name but a few53. 
 
Cost-effectiveness and Cost-benefit analysis of CO2 Vs Air 
Cost-effectiveness is an important factor for patients and medical insurers. Cost effective analysis 
measure and compare the significant gains and losses associated with different methods of patients’ 
management. This aspect of colonoscopy utilizing air versus CO2 could not be analyzed due to lack of 
data across the board. Yamano et al33 is the only study which has analyzed the cost difference between 
the two types of insufflation. According to these authors the total cost of endoscopy with CO2 
increases to 2.5% (about 400 yen) per endoscopy.  
 
To the best of our knowledge the vast majority of day care and endoscopy facilities around the world 
are using air as the primary source for insufflation for endoscopy procedures due to (a) unawareness 
by the endoscopists that CO2 can be substituted for air; (b) fear of CO2 safety due to lack of 
knowledge; (c) unavailability of adequately tailored CO2 insufflalators for endoscopy units especially 
for the older endoscopy stakes; and (d) ignorance regarding cost effectiveness and cost-benefit issues. 
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As none of the RCTs address the cost-effectiveness and cost-benefit issues (direct and indirect costs), 
it is imperative that future RCTs measure these two important aspects of clinical practice to determine 
the utility of treatment (i.e. benefit of treatment multiply by the probability of such benefit minus the 
cost).  
 
LIMITATIONS:  
There are a number of limitations both statistical and clinical in this paper. Firstly, heterogeneity was 
detected within several outcomes variables. (Table 2) Although some degree of heterogeneity is 
inevitable in a medical meta-analysis due to the realities of clinical practice, an I2 index of 50% or 
more can be interpreted as describing significant heterogeneity which may undermine the quality and 
legitimacy of the results obtained (Table 2)54,55. Secondly, publication bias was detected on the funnel 
plots analysis for a number of outcomes56 (Fig 2). Thirdly the inclusion of low quality RCTs based on 
Jadad score may impact the overall results. Fourthly, the correlation between the experienced vs 
novice colonoscopists and abdominal pain are not recorded or analyzed. Fifth, although the vast 
majority of RCTs have used visual analogue scale (VAS), this is a subjective measurement of 
abdominal pain during and in the post-procedural period and therefore caution is required when 
reporting such data. As VAS is highly subjective, it is valuable when looking at change within 
individuals, and is of less value for comparing across a group of individuals at one time point. Sixth, 
as this analysis has combined the pain score data (at various time points) in groups of individuals with 
no sedation, minimum sedation and conscious sedation, this will have some impact on overall results. 
Lastly most of the RCTs except for two have failed to analyze any correlation between the CO2 or air 
volume and pain score, and therefore the impact of gas volume versus pain remains speculative.  
    
CONCLUSIONS: 
On the basis of this meta-analysis and systematic review, we conclude that CO2 insufflation 
significantly reduces abdominal pain during and following the procedure lasting up to 24 hours. There 
is no difference in the cecal/ileal intubation rate and time and total examination time between the two 
methods. Significant CO2 retention during and after the colonoscopy even in sedated patients with 
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pulmonary disease was no different with CO2 insufflation compared to air insufflation and certainly 
has shown no detrimental effects. Therefore CO2 instead of air should be routinely utilized for 
colonoscopy. In the future, however a number of other important issues need to be addressed which 
include the cost-effectiveness, cost-benefit analysis and utility of these two methods of insufflation for 
elective colonoscopy, correlation of experience of colonoscopist versus abdominal pain, the 
relationship between volume of gas and abdominal pain and the role of sedation vs non-sedation. This 
data will have a major impact over practical aspects of medical/surgical practice and patience 
management and policy decisions within institutions and health care insurers. 
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Figure 1: PRISMA flow diagram 
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Figure 2: Funnel plots  
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Figure 3: Procedural and immediate post-procedural pain (during, end or within 15min after procedure) 
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Figure 4. Early post-procedural pain (between 30-120 minutes)
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Figure 5: Intermediate post-procedural pain (360 minutes)
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Figure 6. Late post-procedural pain (720-1440 minutes)
  
  
POOLED OR
0.05 0.25 1.00 15.00
Odds Ratio
Amato et al/2013
Seo et al/2013
Imai et al/2012
Falt et al/2012
Geyer et al/2011
Yamano et al/2010
Riss et al/2009
Liu et al/2009
Bretthauer et al/2005
Sumanac et al/2002
Bretthauer et al/2002
Stevenson et al/1992
4
0
0
0
12
4
16
3
13
7
8
1
/
/
/
/
/
/
/
/
/
/
/
/
115
48
26
84
88
66
134
174
43
46
121
27
11
0
0
0
10
3
15
9
20
9
24
16
/
/
/
/
/
/
/
/
/
/
/
/
113
46
25
85
80
54
117
176
42
51
119
29
0.33 [ 0.10 ,  1.08 ]
0.96 [ 0.02 , 49.32 ]
0.96 [ 0.02 , 50.35 ]
1.01 [ 0.02 , 51.58 ]
1.11 [ 0.45 ,  2.72 ]
1.10 [ 0.23 ,  5.13 ]
0.92 [ 0.43 ,  1.96 ]
0.33 [ 0.09 ,  1.22 ]
0.48 [ 0.20 ,  1.16 ]
0.84 [ 0.28 ,  2.47 ]
0.28 [ 0.12 ,  0.65 ]
0.03 [ 0.00 ,  0.26 ]
0.53 [ 0.34 ,  0.84 ]
Bretthauer et al/2003
Church et al/2003
Wong et al/2008
Uraoka et al/2009
Diez-Redondo et al/2012
Fernandez-Calderon et al/2012
Hsu et al/2012
Mayr et al/2012
Singh et al/2012
Cleland et al/2013
Iida et al/2013
Hsu et al/2014
972/68 937/117
n/N n/N
Study OR [95% CI]CO Air2 Favours CO          Favours Air2
Test for Overall Effect: Z = -2.74, P = 0.01
Test for heterogeneity: Q = 16.53, P = 0.12,  I-sq = 32.02
34 
 
Figure 7: Cecal/ileal intubation rate
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Figure 8. Cecal/ileal intubation time
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Figure 9: Total examination time
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Table 1: Jadad Score 
Author/Year Jadad Score 
 Randomization Blinding Withdrawal/dropouts Total score 
 Randomized Appropriate method Double blinding Appropriate method   
Stevenson GW  et al/1992 1 1 0 1 1 4 
Bretthauer M et al/2002 1 1 1 1 1 5 
Sumanac K et al/2002 1 1 1 1 1 5 
Bretthauer M et al/2003 1 1 1 1 1 5 
Church J et al/2003 1 0 0 0 0 1 
Bretthauer M al/2005 1 1 1 1 1 5 
Wong JCH et al/2008 1 1 1 1 1 5 
Liu X et al/2009 1 1 1 1 1 5 
Riss S et al/2009 1 1 0 0 1 3 
Uraoka T et al/2009 1 1 1 0 1 4 
Yamano  HO et al/2010 1 0 1 0 1 3 
Geyer M et al/2011 1 1 1 1 1 5 
Diez-Redondo P et al/2012 1 1 1 0 1 4 
Falt P et al/2012 1 1 0 0 1 3 
Fernandez-Calderon M et al/2012 1 0 0 0 0 1 
Hsu WH et al/2012 1 0 0 0 1 2 
Imai A et al/2012 1 1 1 1 1 5 
Mayr M et al/2012 1 1 1 1 1 5 
Singh R et al/2012 1 1 1 1 1 5 
Cleland A et al /2013 1 1 1 1 1 5 
Seo EH et al/2013 1 1 1 1 1 5 
Amato A et al/2013 1 1 0 0 0 2 
Iida T et al/2013 1 0 1 1 1 4 
Hsu WF et al/2014 1 1 1 1 1 5 
Jadad Score 
The Jadad scale assesses the quality of published clinical trials based methods relevant to random assignment, double blinding, and the flow of patients. There are 7 items. 
The last 2 attract a negative score, which means that the range of possible scores is 0 (bad) to 5 (good): 
1. Was the study described as randomized (this includes words such as randomly, random, and randomisation)? (+1 Point) 
2. Was the method used to generate the sequence of randomisation described and appropriate (table of random numbers, computer-generated, etc)? (+1 Point) 
3. Was the study described as double blind? (+1 Point) 
4. Was the method of double blinding described and appropriate (identical placebo, active placebo, dummy, etc)? (+1 Point) 
5. Was there a description of withdrawals and dropouts? (+1 Point) 
6. Deduct one point if the method used to generate the sequence of randomisation was described and it was inappropriate (patients were allocated alternately, or according to 
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date of birth, hospital number, etc) 
7. Deduct one point if the study was described as double blind but the method of blinding was inappropriate (e.g., comparison of tablet vs. injection with no double dummy). 
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Table 2: Summary statistics of pooled data 
 
Clinical variables 
 
k 
 
N 
 
Pooled OR/WMD 
(95% CI) 
 
Test for Overall 
Effect 
 
Test for Heterogeneity 
    Z (p-value) Q (p-value) ࡵ૛ (95% CI) 
Procedural and immediate post-procedural Pain (during, 
end or within 15min  after procedure) 
16 2954 0.49 (0.32,0.73)o 
 
-3.46 (0.0005) 73.77(<0.0001)  
df=15 
80.17 (60.78,91.48) 
Early post-procedural pain (between 30-120 min) 13 2196 0.25 (0.12,0.49)o 
 
-3.96 (<0.0001) 139.98(<0.0001) 
df=12 
88.94 (76.90,95.45) 
Intermediate post-procedural pain (360 minutes) 11 1666 0.35 (0.23,0.52)o 
 
-5.14 (<0.0001) 17.68 (0.0606) 
df=10 
41.48 (0.00,87.50) 
Late post-procedural pain (720-1440 minutes) 12 1909 0.53 (0.34,0.84)o 
 
-2.74 (0.0061) 16.53 (0.1225)  
df=11 
32.02 (0.00,83.61) 
Cecal/ileal intubation Rate 13 2281 0.86 (0.61,1.22)o 
 
-0.85 (0.3975) 7.01 (0.8572) 
df=12 
0.00 (0.00, 62.80) 
Cecal/Ileal Intubation Time 14 2331 -0.64 (-1.38,0.09)w -1.72 (0.0860) 34.73 (<0.0001) 
df=13 
54.48 (24.18,89.97) 
Total Examination Time 17 2905 -0.20 (-0.96,0.57)w -0.51 (0.6133) 31.85 (0.0105) 
df=16 
45.92 (4.64,77.66) 
k represents number of studies, N represents number of patients, o represents pooled OR, w represents pooled WMD. 
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Table 3: Salient Feature of RCTs 
Authors/Year/Ref Country/ 
Language 
RC
T 
Patients Male Female Age Routine 
Sedation  
FU Indications 
   CO2 Air CO2 Air CO2 Air CO2 Air    
   n n n n n n Mean 
or 
median 
Mean or 
median 
Yes or No = n Min  
Stevenson GW  et al/1992 Canada/Eng SC 27 29 N/A N/A N/A N/A N/A N/A Yes = 56 1440 Elective - various 
Bretthauer M et al/2002 Norway/Eng SC 121 119 77 75 44 44 59.5  59.6 No=240 1440 Screening (NORCCAP) 
Sumanac K et al/2002 Canada/Eng SC 49 51 N/A N/A N/A N/A 55.9 ± 
1.9 
53.1 ± 1.5 Yes= 100 1440 F/H of CC , Per/H polyp 
Bretthauer M et al/2003 Norway/Eng SC 123 126 77 78 46 48 59 (55-
64) 
59 (55-64) No=249 N/A Screening (NORCCAP) 
Church J et al/2003 USA/Eng SC 123 124 54 73 69 51 N/A N/A Yes = 247 10 Elective - various 
Bretthauer M al/2005 Norway/Eng MC 52 51 N/A N/A N/A N/A 50 (22-
94) 
50 (22-94) Yes = 52, No= 51 1440 Screening 
Wong JCH et al/2008 Hong Kong/Eng SC 44 49 21 23 23 26 59.9 
(15.2) 
58.5 
(12.3) 
Yes=93 120 Elective - various 
Liu X et al/2009 China/Chinese SC 174 175 100 101 74 74 48.5 
(16.8) 
48.1 
(13.2) 
Not routinely,  
Nos not available 
1440 Elective - various 
Riss S et al/2009 Austria/Eng SC 157 143 N/A N/A N/A N/A N/A N/A Yes= 300 720 Elective - various 
Uraoka T et al/2009 Japan/Eng SC 57 57 18 39 19 38 65 (59-
73) 
62 (47-71) Not routinely 
Nos not available 
360 Screening, surveillance & 
diagnostic 
Yamano  HO et al/2010 Japan/Eng SC 66 54 41 37 25 17 63.2 ± 
8.5 
61.7 ± 9.3 No = 120 1440 Screening 
Geyer M et al/2011 Switzerland/Eng SC 110 109 42 68 58 51 58 ± 13 62 ± 12 Yes= 219 1440 screening, surveillance & 
IBD 
Diez-Redondo P et al/2012 Spain/Spanish 
&Eng 
SC 129 141 59 63 70 78 56 (24-
82) 
56.7 (24-
83) 
Yes= 270 1440 Elective - various 
Falt P et al/2012 Czech 
Republic/Eng 
SC 102 101 50 54 52 51 59.4 ± 
14.5 
54 ± 53.5 Yes= 203 1440 Screening, surveillance & 
diagnostic 
Fernandez-Calderon M et 
al/2012 
Spain/Spaish & 
Eng 
SC 132 82 79 52 53 30 59 
(11.6) 
59 (13.2) Yes= 214 120 Elective 
Hsu WH et al/2012 Taiwan/Eng SC 34 33 20 19 14 14 47.9 ± 
14.3 
48.8 ± 
11.3 
No= 67 60 Elective - various 
Imai A et al/2012 Japan/Eng SC 19 18 9 8 10 10 55.7 ± 
18.6 
57.8 ± 
17.7 
No= 37 1440 Elective - IBS 
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Mayr M et al/2012 Germany/Eng SC 77 79 35 32 42 47 62.4 ± 
8.3 (39-
83) 
61 ± 10.9 
(23-77) 
Yes=124, No= 32 1440 Diagnostic & screening 
Singh R et al/2012 Australia/Malaysi
a/Eng 
MC 70 72 45 33 25 39 58.26 
(22-84) 
59.97 (22-
88) 
Yes= 142 N/A Screening, polyp 
surveillance 
Cleland A et al /2013 New Zealand/Eng SC 108 97 51 43 57 54 61.33 ± 
15.79 
61.93 ± 
12.75 
Yes = 205 60 Elective - various 
Seo EH et al/2013 Republic of 
Korea/Eng 
SC 48 46 20 24 28 22 48.8 ± 
9.0 
49.9 ± 8.4 Yes= 94 1440 Screening, surveillance & 
diagnostic 
Amato A et al/2013 Italy/Eng SC 115 113 75 72 40 41 61.5 ± 
14.0 
60 ± 13.4 No=279 
Yes=62 
1440 Screening, surveillance & 
diagnostic 
Iida T et al/2013 Japan/Eng MC 47 50 36 38 11 12 58.9 ± 
10.8 
56.6 ± 
12.2 
No= 97 60 Elective 
Hsu WF et al/2014 Taiwan/Eng SC 60 60 37 31 23 29 54.7 ± 
8.9 
56.3 ± 9.6 Yes= 120 120 Screening 
Eng= English, FU= Follow-up, IBD= Inflammatory bowel disease, MC= Multicenter, Min= Minutes, n= Number, N/A= Not available, NORCCAP= Norwegian colorectal 
cancer prevention, RCT= Randomized Controlled Trial, SC= Single Center,  
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Table 4: Adverse events during colonoscopy with CO2 and Air 
Author/Year Adverse Events 
 CO2 Air 
   
Stevenson GW  et al/1992 N/A N/A 
Bretthauer M et al/2002 0 1 (perforation) 
Sumanac K et al/2002 N/A N/A 
Bretthauer M et al/2003 N/A N/A 
Church J et al/2003 N/A N/A 
Bretthauer M al/2005 N/A N/A 
Wong JCH et al/2008 0 1 (late haemorrhage) 
Liu X et al/2009 N/A N/A 
Riss S et al/2009 0 0 
Uraoka T et al/2009 0 0 
Yamano  HO et al/2010 2 (headache) 1 (headache) 
Geyer M et al/2011 N/A N/A 
Diez-Redondo P et al/2012 N/A N/A 
Falt P et al/2012 N/A N/A 
Fernandez-Calderon M et al/2012 0 0 
Hsu WH et al/2012 N/A N/A 
Imai A et al/2012 N/A N/A 
Mayr M et al/2012 0 0 
Singh R et al/2012 0 0 
Cleland A et al /2013 N/A N/A 
Seo EH et al/2013 0 0 
Amato A et al/2013 0 1 (perforation) 
Iida T et al/2013 N/A N/A 
Hsu WF et al/2014 0 0 
NA= Not available  
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Table 5: CO2 measure during and after colonoscopy 
Author/Year Routine Sedation CO2 measurement during procedure and post-procedural 
  During Procedure Post-procedural CO2 measurement 
 Y or N/Total Mean pressure 
CO2 group 
Air group 
Pts in normal 
range/Total pts 
Mean pressure 
CO2 group 
Air group 
Pts in normal 
range/Total pts 
 
Stevenson GW  et al/1992  N/A N/A N/A N/A  
Bretthauer M et al/2002 N= 240 (T=240) 5.6kPa 
5.4kPa 
75/75 
81/81 
5.5kPa 
5.4kPa 
75/75 
81/81 
ETCO2 
Sumanac K et al/2002  N/A N/A N/A N/A  
Bretthauer M et al/2003  N/A N/A N/A N/A  
Church J et al/2003  N/A N/A N/A N/A  
Bretthauer M al/2005 Y=52, N=51 (T=103) 4.3 kPa 
4.2 kPa 
49/52 
51/51 
4.4 kPa 
4.2 KPa 
52/52 
51/51 
 
Wong JCH et al/2008  N/A N/A N/A N/A  
Liu X et al/2009 Not routinely, numbers not 
available (T=349) 
32.5 mmHg 
32.1 mmHg 
102/102 
103/103 
32.5 mmHg 
32.5 mmHg 
102/102 
103/103 
ETCO2 
Riss S et al/2009  N/A N/A N/A N/A  
Uraoka T et al/2009  <60 mmHg 
<60 mmHg 
57/57 
57/57 
<60 mmHg 
<60 mmHg 
57/57 
57/57 
PtcCO2 
Yamano  HO et al/2010 N= 120 (T=120) 42.5 mmHg 
43 mmHg 
66/66 
54/54 
40 mmHg 
40 mmHg 
66/66 
54/54 
tcpCO2 
Geyer M et al/2011 Y=219 (T=219) 37.3±5.2 mmHg 
35.2±4.3 mmHg 
110/110 
109/109 
37.0±5.2 mmHg 
35.6±6.0 mmHg 
110/110 
109/109 
tcpCO2 
Diez-Redondo P et al/2012 Y=270 (T=270) <30 mmHg 
<30 mm Hg 
72/141 
59/129 
<30 mmHg 
<30 mm Hg 
N/A/141 
N/A/129 
CO2 via 
capnography 
Falt P et al/2012  N/A N/A N/A N/A  
Fernandez-Calderon M et 
al/2012 
 N/A N/A N/A N/A  
Hsu WH et al/2012  N/A N/A N/A N/A PtCO2 
Imai A et al/2012 N=37 (T=27) 39.7 mmHg 
38.5 mmHg 
27/27 
21/21 
39.5 mmHg 
38.3 mmHg 
27/27 
21/21 
PtCO2 
Mayr M et al/2012  N/A N/A N/A N/A  
Singh R et al/2012 Y=142 (T=142) 19.28 
15.1 
70/70 
72/72 
N/A 
N/A 
70/70 
72/72 
Capnography 
readings 
Cleland A et al /2013  N/A N/A N/A N/A  
Seo EH et al/2013 Y=94 (T=94) 37.9 mmHg 48/48 38.6±3.14 mmHg 48/48 ETCO2 
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36.9 mmHg 46/46 37.2±2.40 mmHg 46/46 
Amato A et al/2013  N/A N/A N/A N/A  
Iida T et al/2013  N/A N/A N/A N/A  
Hsu WF et al/2014  N/A N/A N/A N/A  
ETCO2= End Tidal CO2, N= No, N/A= Not available, PtCO2= Transcutaneous partial pressure of CO2, PtcCO2= Processed Transcutaneous CO2, T= Total, tcpCO2= 
Transcutaneous pCO2, Y= Yes 
